SCHEMBL28419134

SCHEMBL28419134

C1CN2CCC1CC2OC1CC2CCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1565902 0.72
SCHEMBL7209544 0.72
SCHEMBL2627863 0.72
Hydrochloric Acid SCHEMBL3930131 0.71
SCHEMBL2021457 0.69 CHRM2 (0.40)
SCHEMBL18290900 0.69 ATM (0.33)
SCHEMBL10930138 0.67
SCHEMBL4279010 0.65 SLC18A3 (0.35)
SCHEMBL8340377 0.61
SCHEMBL3198076 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795117-B Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2020-06-26 CN disclosed